{"task_id": "ae02ce7e13b14420", "source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 185/464)", "text": "w\ngrade B cell lymphoma\nNon-Hodgkin\u2019s Lymphoma\n173\n\n--- Page 195 ---\nPATHOPHYSIOLOGY (CONT\u2019D)\n\u0002\nHAIRY CELL LEUKEMIA (HCL)\n\u0002\nLYMPHOPLASMACYTIC LYMPHOMA (LPL, 2 3%)\npreviously Waldenstrom\u2019s macroglobulinemia\n\u0002\nPLASMA CELL MYELOMA/PLASMACYTOMA (MM)\n\u0002\nAGGRESSIVE B-CELL LYMPHOMAS\n\u0002\nFOLLICULAR LYMPHOMA (FL)\ngrade IIIB (sheets of\ncentroblasts)\n\u0002\nDIFFUSE\nLARGE\nB-CELL\nLYMPHOMA\n(DLBCL,\n30 40%)\nclinical subtypes include primary\nmediastinal B cell lymphoma, primary effusion\nlymphoma (HHV8), and intravascular B cell lym\nphoma. Pathologic subtypes include T cell rich\nB cell lymphoma, anaplastic large cell lym\nphoma, centroblastic, and immunoblastic\n\u0002\nDOUBLE-HIT DLBCL (both c myc and bcl2\ntranslocations)\n\u0002\nLEUKEMIC B-CELL LYMPHOMAS\n\u0002 BURKITT\u2019S LYMPHOMA (BL)\n\u0002\nPRECURSOR B LYMPHOBLASTIC LYMPHOMA (ALL)\n\u0002\nINDOLENT T-CELL LYMPHOMAS\n\u0002\nMYCOSIS FUNGOIDES (mf)\n\u0002\nPRIMARY\nCUTANEOUS\nANAPLASTIC\nLARGE\nCELL\n(PCALC)\n\u0002\nLYMPHOPROLIFERATIVE DISEASE OF LARGE GRANU-\nLAR LYMPHOCYTES (LGL)\n\u0002\nINDOLENT NATURAL KILLER CELL LYMPHOMAS\n\u0002\nNATURAL KILLER CELL LARGE GRANULAR LYMPHO-\nCYTE LEUKEMIA (NK LGL)\n\u0002\nAGGRESSIVE T-CELL LYMPHOMAS\n\u0002\nPERIPHERAL T-CELL LYMPHOMA, NOT OTHERWISE\nSPECIFIED (PTCL NOS)\n\u0002\nPERIPHERAL\nT-CELL\nLYMPHOMA,\nSPECIFIED\nangioimmunoblastic\n(AILD++\ntype),\nnasal\nT/NK cell\ntype,\nsubcutaneous\npanniculitic,\nintestinal enteropathy associated, hepatosple\nnic, anaplastic large cell including null cell\n\u0002\nLEUKEMIC T-CELL LYMPHOMAS\n\u0002\nADULT T-CELL LYMPHOMA/LEUKEMIA (HTLV)\n\u0002\nPRECURSOR T LYMPHOBLASTIC\n\u0002\nLEUKEMIA/LYMPHOMA\nRISK FACTORS\n\u0002\nFAMILY HISTORY\n\u0002\nENVIRONMENTAL\nprevious\nimmunosuppressive\ntherapy, radiation, allogeneic stem cell transplant,\npesticides, agricultural chemicals, smoking, hair\ndyes, geography (e.g. risk of Burkitt\u2019s lymphoma\nis 50\u0003 higher in Africa than in the USA)\n\u0002\nDISEASES\ninfections (HIV, EBV, HHV8, HCV, HTLV,\nHelicobacter pylori), inflammatory disorders (RA,\nSLE, Sjogren\u2019s syndrome, mixed cryoglobulinemia,\ninflammatory bowel disease), inherited immune\ndefects\nPATHOPHYSIOLOGY (CONT\u2019D)\nCLASSIC TRANSLOCATIONS IN LYMPHOMA\n\u0002\nMANTLE CELL LYMPHOMA\nt(11;14) in 95%, cyclin D1\n(bcl1)\n\u0002\nFOLLICULAR\nLYMPHOMA\nt(14;18) in 85%, anti\napoptotic protein (bcl2)\n\u0002\nDIFFUSE LARGE CELL LYMPHOMA\nt(3;14) in 40%, zinc\nfinger transcription factor (bcl6)\n\u0002 MALT\nt(1;14) in < 5%, bcl10\n\u0002 BURKITT\u2019S LYMPHOMA\nt(8;14), t(2;8), or t(8;22) in\n100%, c myc\nINFECTIONS AND LYMPHOMA\n\u0002 EBV\nHodgkin\u2019s lymphoma, Burkitt lymphoma,\npost transplant lymphoproliferative disorders, pri\nmary CNS lymphoma\n\u0002 HCV\nsplenic marginal zone lymphoma\n\u0002 HHV8\nCastleman\ndisease,\nprimary\neffusion\nlymphoma\n\u0002 HIV\nprimary CNS lymphoma\n\u0002 HTLV\nadult T cell leukemia/lymphoma\n\u0002\nBORRELIA BURGDORFERI\ncutaneous marginal zone\nlymphoma\n\u0002\nCAMPYLOBACTER JEJUNI\nsmall bowel marginal zone\nlymphoma\n\u0002\nCHLAMYDIA PSITACCI\neye marginal zone lymphoma\n\u0002\nH. PYLORI\ngastric MALT\nTRANSFORMATION OF INDOLENT LYMPHOMA\n10% of SLL, MZL, and LPL and 60% of FL eventually\ntransform into aggressive DLBCL. Features suggestive\nof transformation include rapid local progression,\nprogression at unusual extranodal sites (CNS, lungs,\nsoft tissue), acute rise in LDH, hypercalcemia, and\nnew onset B symptoms\nCLINICAL FEATURES\nSYMPTOMS\n\u0002\nMASS EFFECT\nlymphadenopathy (occipital, pos\nterior auricular, preauricular, mandibular, sub\nmental, cervical, supra and infraclavicular, Wal\ndeyer\u2019s\nring\n(tonsils,\nbase\nof\ntongue,\nnasopharynx),\nepitrochlear,\naxillary,\ninguinal,\npopliteal),\nhepatosplenomegaly,\nmediastinal/\nabdominal/pelvic/testicular/CNS\nmasses\nmay\ncause\nlocal\ndestruction,\nobstruction,\nand\ncompression\n\u0002\nHEMATOLOGIC\nanemia, thrombocytopenia, lympho\ncytosis\n\u0002\nCONSTITUTIONAL\nB symptoms.\nOther\nconstitu\ntional symptoms include fatigue, anorexia, pruritus\n\u0002\nPARANEOPLASTIC SYNDROMES\nNOTE: lymphoma can mimic many diseases.\nAlways have a high index of suspicion for lym\nphoma, particularly if B symptoms or multisystem\ninvolvement\n174\nNon-Hodgkin\u2019s Lymphoma", "text_length": 3882, "metadata": {"source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 185/464)", "type": "chunk", "chunk_index": 184, "total_chunks": 464, "uploaded_by": "admin@admin.com", "upload_date": "2025-12-11T18:40:09.500114", "document_uuid": "fda2cab4-cdd9-4015-af24-46fd62c86d94", "filename": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf", "category": "medical_pdf", "section": "body", "year": null, "outdated": false, "document_id": "fda2cab4-cdd9-4015-af24-46fd62c86d94"}, "created_at": "2025-12-11T18:40:09.500876", "status": "complete", "chunks_added": 2}